Muutke küpsiste eelistusi

E-raamat: Immunology of Ocular Tumors

Edited by , Edited by , Edited by
  • Formaat: PDF+DRM
  • Ilmumisaeg: 02-Feb-2026
  • Kirjastus: Swets & Zeitlinger
  • Keel: eng
  • ISBN-13: 9781040900260
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 72,79 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Ilmumisaeg: 02-Feb-2026
  • Kirjastus: Swets & Zeitlinger
  • Keel: eng
  • ISBN-13: 9781040900260
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

The eye and the ocular adnexa may give rise to over three hundred histologically different tumors - by far the largest tumor variety of the human body. However, the immunological behavior of these tumors has only been explored in some cases, although it is well established that the eye is an immune-privileged site in which cells that express foreign antigens escape immune-mediated elimination. Human tumors also create an immune-privileged surrounding and thereby escape from anti-tumor immune responses.

Highlighting aspects of ocular and general tumor, this text summarizes the role of the immune system and how tumor tissue can influence various parameters (T-cells, NK-cells, HLA-expression, apoptosis), leading to escape mechanisms used by the tumor. New therapeutic regimens urgently required by patients are also reviewed, and the immunological behavior of skin melanoma is compared to choroidal melanoma, whilst basal cell carcinoma of the ocular lid is compared to those of the skin.
Foreword vii
M. Zierhut
M. Jager
B. Ksander
Clinical remarks on intra- and periocular tumors
1(14)
J. M. Rohrbach
Ocular immune privilege and tumors
15(8)
J. W. Streilein
The role of stroma in the growth or rejection of antigenic solid tumors
23(12)
P. Dubey
L. P. Seung
H. Schreiber
Molecular mechanisms of melanoma cell motility and tissue invasion
35(18)
P. Friedl
K. Maaser
E.-B. Brocker
Cellular and molecular mechanisms of metastatic tumor spread in uveal melanoma
53(8)
D. J. Ruiter
T. J. De Vries
G. N. P. Van Muijen
The pivotal role of VEGF in tumor angiogenesis
61(12)
D. Marme
Natural killer cells and uveal melanoma
73(10)
J. Y. Niederkorn
Specific immune response against tumor antigens defined by cytotoxic T lymphocytes (CTL)
83(8)
E. Jager
D. Jager
A. Knuth
HLA and cancer: β2-Microglobulin mutations and malignant melanoma
91(10)
M. A. Lopez-Nevot
L. Ramal
T. Cabrera
F. Ruiz-Cabello
F. Garrido
HLA antigens of ocular melanoma
101(14)
H. M. H. Hurks
L. R. H. M. Schurmans
J. A. W. Metzelaar-Blok
D. J. R. Blom
M. J. Jager
Antigen expression on uveal melanoma
115(8)
M. J. Jager
D. J. R. Blom
W. R. O. Goslings
J. A. W. Metzelaar-Blok
H. M. H. Hurks
CD40--CD40-ligand-interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity
123(8)
R. E. M. Toes
L. Diehl
A. Th. Den Boer
E. I. H. Van Der Voort
C. J. M. Melief
R. Offringa
The role of apoptosis in cancerogenesis and resistance to therapy: Lessons from malignant glioma
131(10)
M. Weller
W. Wick
J. P. Steinbach
B. Wagenknecht
U. Naumann
W. Roth
Treatment of disseminated uveal melanoma: A continuing dilemma?
141(6)
J. C. Becker
P. Terheyden
E.-B. Brocker
Cytokine therapy and ocular melanoma
147(10)
I. A. Cree
Dendritic cell-based melanoma vaccines
157(12)
L. S. Kierstead
E. Ranieri
J. M. Kirkwood
M. T. Lotze
T. Whiteside
W. J. Storkus
Immunology of basal cell carcinoma of the lid
169(14)
M. Zierhut
R. Stiemer
B. Wannke
A. Mayer
J. M. Rohrbach
CD44 expression and invasiveness in basal cell carcinoma
183(18)
K. P. Dingemans
P. K. Das
Recognition of lymphoma cells by human γδ T lymphocytes
201(10)
P. Fisch
Somatic mutation analysis of ocular adnexal extranodal marginal zone B-cell lymphomas
211(12)
S. E. Coupland
M. Hummel
H. Stein
Immunopathology and molecular biology of primary intraocular lymphoma
223(14)
C.-C. Chan
D. F. Shen
R. R. Buggage
Immunology of paraneoplastic syndromes
237(18)
C. E. Thirkill
Index 255


M. Jager, B.R. Ksander; M. Zierhut